In turn, a protective effect of intraperitoneal nesfatin-1 treatment on the densitometric, tomographic, and mechanical bone parameters in developing osteopenia in female rats was shown in our earlier study [42]. This evidence concerns the gene NUCB2 and Osteopenia.